What is OJJAARA prescribed for? OJJAARA is prescribed to treat intermediate or high-risk myelofibrosis in adults with anemia. What is the name of the drug and what does it do? OJJAARA, pronounced oh-JAR-uh, (generic name: momelotinib) is a medication approved on September 15, 2023, for the treatment of adults with intermediate or high-risk myelofibrosis,...
